Hyperfine Price to Sales Ratio 2021-2024 | HYPR
Hyperfine P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2025-05-02 | 0.69 | 3.87 | |
2024-12-31 | 0.88 | $0.18 | 4.93 |
2024-09-30 | 1.08 | $0.18 | 5.87 |
2024-06-30 | 0.85 | $0.17 | 5.11 |
2024-03-31 | 1.00 | $0.16 | 6.11 |
2023-12-31 | 1.12 | $0.15 | 7.23 |
2023-09-30 | 2.05 | $0.14 | 14.91 |
2023-06-30 | 2.15 | $0.14 | 15.56 |
2023-03-31 | 1.44 | $0.11 | 12.80 |
2022-12-31 | 0.84 | $0.10 | 8.68 |
2022-09-30 | 0.81 | $0.19 | 4.16 |
2022-06-30 | 2.23 | $0.36 | 6.24 |
2022-03-31 | 3.54 | $0.55 | 6.42 |
2021-12-31 | 7.25 | $0.74 | 9.84 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED INSTRUMENTS | $0.054B | $0.013B |
Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn. |